Basic Science meetings & conferences

Society for Immunotherapy of Cancer 27th Annual Meeting

October 26-28, 2012 North Bethesda, Maryland

The SITC 27th Annual Meeting allows for scientific exchange of the most cutting-edge preclinical and clinical data on immunotherapies and biological therapy of cancer. The program included dynamic presentations, interactive panel discussions and scientific posters on the most timely topics in cancer immunotherapy as well as vital information on clinical trial design and regulatory issues to advance collaboration and translation of cancer immunotherapies.

SITC is ideally positioned to meet the identified needs of our attendees. SITC’s strength lies in its history of organizing successful scientific conferences that gather clinicians and scientists from around the globe to interact and discuss the most important issues in cancer immunotherapy. By addressing these needs, SITC advances effective, efficient research and interaction on promising cancer therapies with biological and immunological agents. Through its integrated programs, SITC promotes productive collaboration among scientists and with other organizations in the field. Ultimately this scientific exchange and collaborative environment will lead to better cancer patient outcomes with novel cancer immunotherapies.

The SITC 27th Annual Meeting program format and content is designed to address identified needs/practice gaps and promotes:

Exchange between basic and clinical researchers, thus improving the caliber of the science and promoting translation
Discussion on potential hurdles in cancer immunotherapy from the trial design and regulatory perspective
Integrated understanding of the state of cancer immunotherapy research in today’s environment, identification of potential funding opportunities, and mentoring of junior investigators
Discussion of novel therapies and applications based on the research presented
Interactions with industry to promote access to novel agents for clinical development

Intended Audience

The audience for this program is basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, postdoctoral fellows, and allied health professionals involved in cancer research.

Program Goals

Exchange information on the most recent advances in tumor immunology and cancer immunotherapy
Convey recent advances in biology and immunotherapy as they relate to specific cancers and various immunotherapy modalities, cell subsets, animal models, and aspects of negative regulation in the tumor microenvironment
Identify promising research opportunities, new techniques and clinical applications incorporating these advances
Establish dialogue between academia, industry and government on these advances

Expected Learner Outcomes

Upon completion of this program, the participants will be able to:

Summarize the most recent advances in tumor immunology and cancer immunotherapy
Integrate recent advances in cancer immunology and immunotherapy into basic, clinical and translational research
Incorporate new research and techniques into clinical applications for cancer immunotherapy
Establish and solidify collaborations among the various members of academia, industry, government and clinical practices to promote clinical evaluation of these advances in more efficient trials

2012 American Society for Cell Biology Annual Meeting

December 15-19, 2012 San Francisco, California

Highlights:

Keynote Symposium by Steven Chu, U.S. Secretary of Energy, and Arthur D. Levinson, Chair, Genentech, Inc., and Apple, Inc.
Threads (meetings-within-a-meeting):1) Cell Biology and Medicine and 2) Cell Biology and the Physical Sciences. Daily programs will allow attendees to follow new fields while benefitting from a large meeting with the best research in cell biology.
World-class Symposia and Minisymposia speakers
Frontier Symposia will synthesize current, exciting progress in the field
Science Discussion Tables—interact with senior scientists in an intimate setting
Posters, mentorship, networking, career development, and education programs

Fun in the wonderful city of San Francisco!

8th Congress of the European Federation of IASP Chapters - Europe against Pain 2013

Join us in Florence, Italy for Pain in Europe VIII. EFIC 2013 congress, taking place October 9-12, brings together over 4,000 pain specialists for a multidisciplinary forum that will focus on the latest developments in the study and treatment of acute or chronic and recurrent pain.

Presented by a leading international faculty, the scientific programme promises to provide new insights into basic science, clinical research and therapeutic interventions.

Secretariat and Congress Organisers

EFIC 2013 Congress Secretariat
Kenes International
1-3 rue de Chantepoulet, PO BOX 1726
CH-1211 Geneva, Switzerland
Tel: +41 22 908 0488
Fax: +41 22 906 9140
E-mail: efic2013@kenes.com
Website: www.kenes.com/efic

Aging and Diseases of Aging

22 Oct 2012 through 27 Oct 2012 Tokyo, Japan

LANGUAGE NOTE: This meeting will be conducted in English.

Age-related diseases and disabilities, such as cancer, diabetes, and neuronal degeneration, pose an ever increasing social and economic burden worldwide. Fortunately, the last decades have witnessed dramatic progress in our understanding of the aging process. Genetic studies in particular have helped elucidate some of the molecular pathways that regulate the aging and offered new insights into the treatment of age-related diseases. However, there is still much to be learned and further progress in addressing the unique challenges of the aging population will require new insights and novel approaches. In order to accelerate the discovery process, this Keystone Symposia meeting will cover essential aspects of the aging processes, including cell signaling pathways, DNA stability, protein homeostasis, stem cells and cellular senescence. Each plenary session will emphasize innovative findings from a variety of models in basic research areas and link them to age-related disease and frailty. The ultimate goal is to provide an opportunity for attendees to communicate and promote an integrated understanding of aging and age-related diseases. The program for this meeting is highly likely to attract a wide variety of investigators, many of whom might not otherwise interact.

Keystone Symposia
Phone: +1 (800) 253-0685 or +1 (970) 262-1230
Fax: +1 (970) 262-1525
info@keystonesymposia.org

Society for Acupuncture Research 2013 Conference

Impact of Acupuncture Research on 21st Century Health Care

April 19-21, 2013 University of Michigan Ann Arbor, Michigan, USA

Co-sponsored by: University of Michigan Department of Anesthesiology and Program in Integrative Medicine

The rising incidence of chronic disease and stress-related illness in the West has led to an increased utilization of acupuncture
as a contemporary health care option. A major reason for this increase in usage is that acupuncture has heeded the call for evidence-based medicine, with a broad range of clinical trials, surveys of safety, and basic science studies of physiological action all contributing to its growing acceptance. The 2013 SAR conference will explore diverse areas of acupuncture research, emphasizing their potential to affect health policy decisions and enhance clinical practice.

-- Leading researchers from the U.S. and abroad will present keynote addresses, participate in symposia and panels, and lead workshops assessing recent progress, challenges and opportunities for the field.

-- Representative speakers from the national and international acupuncture research communities will present original data in three major areas: clinical research, basic science and research methodology.

-- A pre-conference workshop will focus on “Current status and issues in acupuncture research for practitioners, students, and educators new to this field.”

See www.acupunctureresearch.org for more details about the conference program as available.

International Conference on Biomolecular Engineering

The 2013 ICBE will be held in Fort Lauderdale, Florida January 13-16, 2013

ICBE brings together researchers who are using quantitative approaches to advance the understanding and application of molecular biology. These scientists, engineers, and professionals are contributing to the development of analytical, diagnostic, and therapeutic strategies that are directly relevant to public health. The conference, co-chaired by Ali Khademhosseini (Harvard University) and Kristala Prather (MIT) will stimulate efforts to integrate these approaches across the scales of biological complexity in a single-track Gordon-style conference format that includes hotel accommodations and most meals.

ICBE 2013 Sessions include:

Biomolecular Engineering for Cell and Tissue Engineering
Biophysical and Microscale Analyses of Molecular and Cellular Function
Experimental & Computational Tools for Engineering Biomolecules
Interface of Bionanotechnology and Biomolecules
Metabolic Pathway Engineering
Protein Engineering
Synthetic Biology

Contact Us

For additional information about ICBE, please email us at bio@aiche.org.

Cervical Spine Research Society 40th Annual Meeting

December 6 – 8, 2012 Chicago, Illinois

The Cervical Spine Research Society is a multidisciplinary organization that provides a forum for the exchange of ideas and promotes clinical and basic science research of the cervical spine. The organization values collegial interaction and strong scientific principles.

American Society of Human Genetics 62nd Annual Meeting

Tuesday, November 6 through Saturday, November 10, 2012 San Francisco, California

The world's top scientists and clinicians in the human genetics field will gather to present their latest research findings at the 62nd Annual Meeting of the American Society of Human Genetics (ASHG), which will be held on November 6-10, 2012, in San Francisco, CA (http://www.ashg.org/2012meeting). ASHG is the primary professional membership organization for human genetics specialists worldwide, representing nearly 8,000 researchers, academicians, clinicians, genetic counselors, nurses, and others with a special interest in this area (http://www.ashg.org).

The ASHG Annual Meeting continues to be the largest human genetics meeting in the world, attracting more than 7,000 scientific participants each year. The ASHG 2012 Meeting will provide attendees with the latest information about cutting-edge developments in human genetics and genomics research. In addition, nearly 250 U.S. and international exhibitors at this year's ASHG Exhibitor Trade Show will offer an unprecedented opportunity to view the latest advances in genetics-related products and services derived, in part, from work presented at previous ASHG meetings.

Topics to be addressed in the scientific program for the ASHG 2012 Meeting will include: gene discovery in human genetics; new insights and challenges from next generation sequencing; advances in medical genetics and translation/applications in clinical care; progress in gene therapy; personalized medicine; cancer genetics; advances in non-invasive prenatal diagnosis; revelations about human alleles from studies of model organisms; implications of population genetic studies; modeling in statistical genetics; data centralization and its implications for our field; ethical, legal and social implications of genomics; changes in genetics education; and much more.

For more information about the ASHG 2012 Annual Meeting, or to register and/or submit an abstract for presentation at this year’s meeting, please go to: http://www.ashg.org/2012meeting.

Inducing and Breaking Tolerogenic Antigen-Presenting Cell Function

Thursday, 5 July 2012 London, United Kingdom

Professional antigen-presenting cells (APC) such as dendritic cells (DC) and macrophages play a critical role in the initiation and maintenance of a T cell-mediated immune response. APC are essential for T cell priming, differentiation and activation in lymphoid tissue and at sites of inflammation. Understanding the molecular mechanisms via which APC function can be controlled may give novel insights into how T cell mediated immunity may be induced or blocked. This meeting will highlight current research aimed at inducing APC with tolerogenic function in order to treat inflammatory disease (e.g. rheumatoid arthritis) as well as work aimed at boosting the immunostimulatory function of APC in the context of cancer. The meeting will also highlight recent progress on the suppressive effects of CD4+ regulatory T cells on APC function, and how these can be overcome.

This event has CPD accreditation and will have a discussion panel session.

On registration you will be able to submit your questions to the panel that will be asked by the chair on the day of the event

Meeting chairs: Dr Leonie Taams, Senior Lecturer in Immunology, King's College London Centre for Molecular and Cellular Biology of Inflammation and Dr Catharien Hilkens, Reader in Immunotherapy, Newcastle University , UK

Email: enquiries@euroscicon.com

Web: www.euroscicon.com

For all accommodation and travel enquiries please contact accommodationandtravel@euroscicon.com

Annual Biomedical Research Conference for Minority Students

November 7-10, 2012 San Jose, California

ABRCMS
American Society for Microbiology Education Department
1752 N Street, NW
Washington, DC 20036

Ph: 202-942-9348
Fax: 202-403-3513

Email:abrcms@asmusa.org